Matt Dimond
@Matt_Dimond1
Followers
76
Following
246
Media
3
Statuses
65
MS-3 @LoyolaHealth, Clemson '21, Heart Failure Collaboratory, Inova Health System @hfcollaboratory
Joined July 2021
Huge congratulations again to the site-based research award recipients! Well deserved for their dedication to their respective fields 👏👏 👏
0
6
13
SIMULTANEOUS PUBLICATION OUT NOW🗣️ Click the link below to read Yasmire’s paper on clinical research’s unsung HEROES and the importance of rewarding site-based research ⬇️ https://t.co/NzOypHwXXj
@dranulala @mfiuzat @coconnormd @MariellJessup @yasmireshardae
ahajournals.org
1
3
6
Me and @Matt_Dimond1 -so proud of you and what you have accomplished! @LoyolaStritch Catherine Kim plans to follow in his footsteps !
0
2
11
Congratulations @Matt_Dimond1 on completion of his research on factors associated with better BP control among physician patient panels. Turns out BP measurement method is a lot! @LoyolaStritch @LoyolaParkinson #stalbertsday @LoyolaChicago
0
2
2
Do BP control Quality Improvement (QI) initiatives work?? NEW @LoyolaHealth: ⬆️ physician AOBP measurement and ⬆️ 30-day patient follow up when BP is elevated = ⬆️ rates of physician #HTN control!! Huge thanks to @kramer_holly for her leadership on this project! #HTN #AOBP
Congratulations @Matt_Dimond1 on completion of his research on factors associated with better BP control among physician patient panels. Turns out BP measurement method is a lot! @LoyolaStritch @LoyolaParkinson #stalbertsday @LoyolaChicago
0
0
1
Feasibility and safety of apixaban in patients with an LVAD was evaluated in DOAC LVAD study. Results reported in #JACCHF
@PalakShahMD @coconnormd
0
9
25
@Matt_Dimond1 @hfcollaboratory @coconnormd @mfiuzat @IsabellaCavagna @robmentz @vbluml @mpsotka Incredible mentorship from @mfiuzat and all star ✨✨✨interns make for an incredible program @hfcollaboratory
0
1
2
How can we call attention to the lack of diversity in clinical trials at a Congressional level? @meghakgupta presents at #ACC2024 on the HFC Letter to Congress to reconsider demographic legislation and the HFC recommendations to enhance underrepresented enrollment in HF trials
0
6
10
How can we utilize community organizations to improve diversity in clinical trials? @iamyasdoll Presenting on how HFC and National Pan-Hellenic Councils can bring awareness to Black patients and underserved communities of the critical lack of diversity in HF clinical trials.
1
3
11
Great insights from @IsabellaCavagna at #ACC2024 today about the impact of #ClinicalTrial demographics on early adoption of breakthrough #MedTech. Now available in @JACCJournals: https://t.co/Cme5mnpgF8 US Safety Info: https://t.co/aNKN4o4LmB
0
4
12
Happy birthday to HFC Intern @meghakgupta 🎊🥳 What a great way to celebrate at your first ACC conference!
1
4
10
#SimPub in @JACCJournals Does HF trial enrollment contribute to underutilization of therapies among diverse groups in clinical practice? HFC Intern @IsabellaCavagna presents on Clinical Trial Inclusion manuscript out now at the link below🔗 https://t.co/tGd54epXdq
0
5
16
💡NEW State-of-the-Art Review on HFC’s efforts to train the next generation of members and create a standardized approach to data reporting, DMC conduct, & new member training to help address the growing demand for experienced DMC members Read below ⬇️ https://t.co/rjUSvEYvFt
0
2
7
HFC Special Focus meeting starting now… @coconnormd @mfiuzat @hmkyale @SnehaShahJain setting the stage for the meeting with the importance of #AI and how the HF community can embrace this groundbreaking technology
0
7
15
And that’s a wrap! @PalakShahMD closes #THT2024 with a BANG exploring promise & potential of #microRNA in #transplant #rejection @coconnormd @mpsotka @vbluml @ISHVnews @InovaHealth @InovaCVfellows @KiranKhush1
0
9
30
@docbhardwaj @JACCJournals @hfcollaboratory @mfiuzat @JavedButler1 @DukeHFDoc @Nikhil15 @slumberbell @JTThibs @adrianjdasilva @BiykemB #HFmrEF doesn’t exist: from a clinical context it adds unneeded confusion, from a research context it is an oversimplification of the continuous spectrum of LVEF.
1
3
14
The @ISHVnews Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study -- a Featured Late-Breaker at #THT To be presented by @PalakShahMD @crfheart @crfconferences
0
9
22
@PalakShahMD shares #LBCT results #DOAC #LVAD pilot study #THT2024 Time now 4 pivotal RCT on anticoagulation in durable #MCS? @coconnormd @mpsotka @iyadisseh @MaryLoobyPharmD @ISHVnews @InovaHealth @InovaCVfellows
2
14
46
A new model for training the next generation of clinical investigators, gap year HFC interns , Congrats !
HFC Interns have FOUR abstracts accepted for presentation at the @ACCinTouch conference this spring in Atlanta, GA. Don’t forget to stop by the poster sessions 🎉 Specific times of presentations still to come @iamyasdoll @MeghaGu86063358 @IsabellaCavagna #ACC24
0
6
15
In #JACCHF REVIEW TOPIC OF THE MONTH, @Matt_Dimond1, @mpsotka, et al present results of @HFCollaboratory review of role of LVEF in categorization of HF, and provide recommendations for future of HF phenotyping https://t.co/GQznykbu9Z
0
5
13